Showing results (331-340 of 375) with videos related to

Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|March 10, 2019
Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetesDavid Russell-Jones, Arnaud Dauchy, Elías Delgado, et al.
Cell Reports|March 28, 2019
The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen ResistanceLeeanna El-Houjeiri, Elite Possik, Tarika Vijayaraghavan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adultsJ Gibney, M L Healy, M Stolinski, et al.
Diabetes|July 25, 2000
IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clampP V Carroll, E R Christ, A M Umpleby, et al.
Environmental Health : a Global Access Science Source|November 6, 2015
Projections of temperature-attributable premature deaths in 209 U.S. cities using a cluster-based Poisson approachJoel D Schwartz, Mihye Lee, Patrick L Kinney, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patientsJ Gibney, J D Wallace, T Spinks, et al.
Lancet (London, England)|April 24, 2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialSimon Heller, John Buse, Miles Fisher, et al.
Diabetes Care|July 10, 2020
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, et al.
Diabetes Care|March 21, 2022
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 DiabetesRoselle A Herring, Fariba Shojaee-Moradie, Mary Stevenage, et al.
Metabolism: Clinical and Experimental|March 27, 2012
Fatty acid flux and oxidation are increased by rimonabant in obese womenKatharine Backhouse, Ivana Sarac, Fariba Shojaee-Moradie, et al.
Pageof 38